Sugishita K, Maezawa M, Miyasaka K, Hirofuji S, Yamashita M, Nokura Y
Cureus. 2025; 17(2):e78585.
PMID: 40062164
PMC: 11888994.
DOI: 10.7759/cureus.78585.
Reichen C, Beirao B, Monteiro A
Vet Res Commun. 2025; 49(2):115.
PMID: 39992468
DOI: 10.1007/s11259-025-10677-0.
Correa Rassele A, Oliveira Almeida I, Garschagen Gava M, Bronhara Pimentel P, Giuliano A, Ruiz Sueiro F
Animals (Basel). 2025; 15(2).
PMID: 39858283
PMC: 11761284.
DOI: 10.3390/ani15020283.
Fasoulopoulos A, Varras M, Varra F, Philippou A, Myoteri D, Varra V
Mol Med Rep. 2025; 31(3.
PMID: 39791214
PMC: 11751665.
DOI: 10.3892/mmr.2025.13434.
Jia Z, Maishi N, Takekawa H, Matsuda A, Nakade T, Nakamura T
Cancer Med. 2024; 13(23):e70462.
PMID: 39629553
PMC: 11615514.
DOI: 10.1002/cam4.70462.
Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumor.
Na J, Jeon J, Huh K, Yu K, Lee S, Eom J
Cancer Sci. 2024; 115(12):3943-3951.
PMID: 39375952
PMC: 11611764.
DOI: 10.1111/cas.16363.
Hypertension toxicity of VEGFR-TKIs in cancer treatment: incidence, mechanisms, and management strategies.
Du Y, Li X, Ji S, Niu N
Arch Toxicol. 2024; 99(1):67-81.
PMID: 39347999
DOI: 10.1007/s00204-024-03874-4.
Critical appraisal of the chorioallantoic membrane model for studying angiogenesis in preclinical research.
Shekatkar M, Kheur S, Deshpande S, Sakhare S, Sanap A, Kheur M
Mol Biol Rep. 2024; 51(1):1026.
PMID: 39340708
DOI: 10.1007/s11033-024-09956-x.
Decoy receptors as biomarkers for exploring aetiology and designing new therapies.
Zoccali C, Tripepi G, Stel V, Fu E, Mallamaci F, Dekker F
Clin Kidney J. 2024; 17(8):sfae222.
PMID: 39184952
PMC: 11341986.
DOI: 10.1093/ckj/sfae222.
Extracellular vesicle-bound VEGF in oral squamous cell carcinoma and its role in resistance to Bevacizumab Therapy.
Zhou J, Liu X, Dong Q, Li J, Niu W, Liu T
Cancer Cell Int. 2024; 24(1):296.
PMID: 39180066
PMC: 11344308.
DOI: 10.1186/s12935-024-03476-1.
Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.
Liu Y, Chen X, Chen X, Chen J, Zhang H, Xu H
J Nanobiotechnology. 2024; 22(1):417.
PMID: 39014353
PMC: 11253443.
DOI: 10.1186/s12951-024-02668-1.
Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer.
Sarwar F, Ashhad S, Vimal A, Vishvakarma R
Med Oncol. 2024; 41(8):199.
PMID: 38985225
DOI: 10.1007/s12032-024-02446-x.
Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens.
Zhang S, Wang H, Ding X, Xiao Y, Shao Z, You C
Fundam Res. 2024; 3(6):1005-1024.
PMID: 38933006
PMC: 11197801.
DOI: 10.1016/j.fmre.2022.03.009.
Molecular regulators of defective placental and cardiovascular development in fetal growth restriction.
Umapathy A, Clark A, Sehgal A, Karanam V, Rajaraman G, Kalionis B
Clin Sci (Lond). 2024; 138(13):761-775.
PMID: 38904187
PMC: 11193155.
DOI: 10.1042/CS20220428.
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic and non-diabetic retinopathy: associated factors and anatomical correlation.
Al-Dwairi R, El-Elimat T, Aleshawi A, Al Sharie A, Al Beiruti S, Sharayah A
Int J Retina Vitreous. 2024; 10(1):38.
PMID: 38773581
PMC: 11106866.
DOI: 10.1186/s40942-024-00556-2.
Parenchymal cues define Vegfa-driven venous angiogenesis by activating a sprouting competent venous endothelial subtype.
Preau L, Lischke A, Merkel M, Oegel N, Weissenbruch M, Michael A
Nat Commun. 2024; 15(1):3118.
PMID: 38600061
PMC: 11006894.
DOI: 10.1038/s41467-024-47434-x.
Are There Any Differences in the Healing Capacity between the Medial Collateral Ligament's (MCL) Proximal and Distal Parts in the Human Knee? Quantitative and Immunohistochemical Analysis of CD34, α-Smooth Muscle Actin (α-SMA), and Vascular....
Georgiev G, Yordanov Y, Gaydarski L, Tubbs R, Olewnik L, Zielinska N
Biomedicines. 2024; 12(3).
PMID: 38540272
PMC: 10967725.
DOI: 10.3390/biomedicines12030659.
Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis.
Wu J, He X, Qi F, Zhao Z, Xu Z, Yan H
Ophthalmol Ther. 2024; 13(5):1255-1269.
PMID: 38498277
PMC: 11039604.
DOI: 10.1007/s40123-024-00915-0.
Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment.
Logghe T, van Zwol E, Immordino B, Van den Cruys K, Peeters M, Giovannetti E
Cancers (Basel). 2024; 16(3).
PMID: 38339258
PMC: 10854776.
DOI: 10.3390/cancers16030505.
evaluation of the antitumor activity of axitinib in canine mammary gland tumor cell lines.
Lee H, Lim G, An J, Park S, Seo K, Youn H
J Vet Sci. 2024; 25(1):e1.
PMID: 38311316
PMC: 10839173.
DOI: 10.4142/jvs.23191.
